Strains of the gastrointestinal species Lactobacillus reuteri were electrotransformed with plasmid constructs containing the endo-1,3-1,4-␤-glucanase gene (bglM) of Bacillus macerans. The enzyme was expressed and secreted by the lactobacilli. A plasmid construct containing the bglM gene lacking its promoter was derived and was demonstrated to be useful as a promoter probe vector.
Lactobacilli are common inhabitants of the digestive tracts of mammalian species and are often constituents of living preparations of bacteria (probiotics) that are fed to farm animals with the aim of increasing weight gain and improving feed conversion (18) . The mechanisms by which probiotics containing lactobacilli promote animal welfare are ill-defined but are generally assumed to involve modification of the normal microflora of the digestive tract by the ingested bacteria (8) . It has been speculated that more efficacious probiotics whose beneficial effects can be scientifically validated may be derived through the genetic modification of gastrointestinal strains of lactobacilli (17) . These modified strains would, it has been proposed, colonize the digestive tract after consumption by the animal host and synthesize a novel product. This product would have a predictable and demonstrable effect on the animal. Unfortunately, the derivation of genetically modified strains of intestinal lactobacilli has proved difficult (23) , largely because suitable plasmid expression vectors with strong promoters of Lactobacillus origin have not been developed and because easily detected markers of gene expression (other than antibiotic resistance determinants) have not been used. Genes encoding endo-␤-glucanases, which hydrolyze glucopyranose polymers (␤-D-glucans), may be useful as reporter genes in the derivation of promoter probe vectors because several endoglucanase genes from gram-positive species have been expressed in lactobacilli (1, 2, 16) . The genes originated from Bacillus and Clostridium species and were endo-1,4-␤-glucanases which specifically hydrolyzed 1,4-␤-D-glucans such as carboxymethyl cellulose. Bacillus macerans produces and secretes an endo-1,3-1,4-␤-glucanase (BglM; EC 3.2.1.73) which preferentially hydrolyzes glucans containing a mixture of ␤-1,3 and ␤-1,4 linkages such as lichenin (lichenan) and barley ␤-glucan (4). This enzyme is well-characterized both biochemically and genetically and has been used for the construction of hybrid ␤-glucanases with improved activities (4, 14) . We describe here the cloning, expression, and secretion of the B. macerans endo-1,3-1,4-␤-glucanase gene, bglM, in a strain of Lactobacillus reuteri originating in the gastrointestinal tract. The activity of the enzyme could be detected by a simple agar plate assay. Additionally, a recombinant plasmid that we have derived containing a promoterless bglM gene should prove useful as a promoter probe vector system for use with L. reuteri.
Bacterial strains used in this work are listed in Table 1 .
Escherichia coli DH5␣FЈ was cultured in Luria broth (Difco Laboratories, Detroit, Mich.) incubated at 37°C aerobically. L. reuteri strains were cultured in Lactobacilli MRS medium (Difco) under anaerobic conditions at 37°C. Solidified culture media contained 1.5% (wt/vol) agar. Ampicillin (50 g/ml) and erythromycin (500 g/ml for E. coli, 50 g/ml for lactobacilli) were added to media as required. Recombinant DNA techniques used during the study were those described by Sambrook and colleagues (15) . Restriction endonucleases and T4 DNA ligase were purchased from Boehringer (Mannheim, Germany) and were used according to the manufacturer's instructions. For end filling of restriction sites to create blunt ends, we used Klenow fragment enzyme (Boehringer). Plasmid DNA was detected in lactobacilli by using the method of Tannock et al. (20) . For extraction and purification of DNA fragments from agarose gels, we used a GeneClean kit (Bio 101 Inc., La Jolla, Calif.). Recombinant DNA molecules were introduced into E. coli or Lactobacillus cells by electrotransformation (6, 13) . Production of ␤-glucanase by Lactobacillus strains was detected by an agar plate assay in which the surface of PHB agar (per liter, 12 g of Todd-Hewitt broth, 3 g of Lactobacilli MRS medium, 15 g of agar [12] ) supplemented with 0.1% (vol/vol) Tween 80 (Sigma Chemical Co.) and 0.05% (wt/vol) lichenan (Sigma) was inoculated with bacterial cells.
To test E. coli transformants, we used Luria agar containing 0.05% (wt/vol) lichenan. In either case, after overnight incubation, the surface of the plate was flooded with a 0.1% (wt/ vol) solution of Congo red (dissolved in 20% ethanol). ␤-Glucanase activity was shown by a yellow zone surrounding the bacterial growth on an otherwise red-colored plate (21) (Fig.  1 ). Plasmid pNCKH104 was derived from pUC29. It is an E. coli-L. reuteri shuttle vector containing the bifunctional erythromycin resistance determinant ermGT (19) in place of the ␤-lactamase gene and a 1.7-kb PvuII-NcoI replicon fragment from pGT232, which is an indigenous plasmid of L. reuteri 100-23 (Fig. 2) . The bglM gene was purified as a 0.85-kb EcoRI-PstI fragment from plasmid pTZ19-Mac (11). The EcoRI site was end filled, and the fragment was inserted into the blunt-ended SalI-PstI site of pNCKH104, generating pNCKH111 (Fig. 2) . Plasmid pNCKH111 was used to electrotransform L. reuteri strains DSM 20016 and 100-23C. Transformants (Em r ) of the two strains were obtained at a frequency of 2.2 ϫ 10 6 and 1.3 ϫ 10 3 per g of DNA, respectively. Forty transformants of each bacterial strain were tested for ␤-glucanase production by the plate assay; all produced the enzyme and contained a plasmid identical by plasmid profiling to pNCKH111. These transformants apparently expressed and secreted bglM under the control of its own expression and secretion signals.
To determine if the ␤-glucanase activity was due to secretion of the enzyme or due to cell lysis during incubation, it was necessary to (i) determine the amounts of ␤-glucanase in the culture supernatant (extracellular) and bacterial cell (intracellular) fractions and (ii) determine the extent of cell lysis. These experiments utilized a 16-h culture of L. reuteri NH111 grown in erythromycin-containing MRS broth. The culture was centrifuged (9,820 ϫ g for 10 min at 5°C). The cell pellet was resuspended in 1/10 volume of 0.1 M sodium phosphate buffer (pH 6.5), and the cells were lysed by repeated passage through a French pressure cell (American Instrument Co.) at 20,000 lb/in 2 . Cellular debris was subsequently removed by centrifugation (48,400 ϫ g for 15 min at 4°C), and the clarified extract was retained for subsequent enzyme analyses. It has been reported that BglM is acid labile (14) . As the culture supernatant was acidic (pH 4.0 to 4.5), it was necessary to alter the pH by dialysis against deionized water followed by equilibration in 0.1 M sodium phosphate buffer (pH 6.5). ␤-Glucanase activity was determined by measuring the amounts of reducing sugars (as glucose equivalents) liberated by fractions incubated with 0.05% (wt/vol) lichenan as the substrate. Reducing sugars were estimated by the 2,2Ј-bicinchoninate method (22) . To measure the degree of bacterial cell lysis during culture, the amount of ␤-galactosidase (a cytoplasmic enzyme) was determined for each fraction as described by Sambrook et al. (15) .
Approximately 58% of the total ␤-glucanase activity of the culture of strain NH111 was present in the extracellular fraction ( Table 2 ). The specific activity of ␤-glucanase was 2.5-fold higher in the extracellular than in the intracellular fraction ( Table 2 ). The extracellular ␤-glucanase activity was not due only to cell lysis, because 95% of the total ␤-galactosidase activity was located in the intracellular fraction (Table 2) lichenan per hour compared to micromole quantities reported for L. plantarum (16) . Nevertheless, the amount of enzyme produced by L. reuteri was easily detected by the plate assay. We then sought to construct a promoter probe vector incorporating the bglM gene. To accomplish this, a promoterless 0.78-kb DraI-PstI fragment of bglM (bglMЈ) was inserted into plasmid pNCKH104 to give pNCKH112 (Fig. 2) . The DraI site of bglM is located within the Ϫ10 promoter region of the gene (4). Interestingly, ␤-glucanase activity was detected in Lactobacillus transformants containing pNCKH112, indicating that vector sequences upstream of bglMЈ contributed to the expression of the gene. To abolish promoter activity due to vector DNA, a DNA fragment from the expression vector pKK223-3 (5) containing the E. coli rho-independent transcription terminators rrnBT 1 and -T 2 was cloned directly upstream from bglMЈ. This was achieved in a multistep process. First, the rrnBT 1 and -T 2 terminators were cloned as a 0.47-kb end-filled HindIII-RcaI fragment from pKK223-3 into the NruI and NcoI sites of pUC29, yielding p29T. The bglMЈ gene was then inserted into pUC29T as a 0.82-kb XbaI-HindIII fragment from pNCKH112, giving p29TbglMЈ. Finally, the rrnBT 1 T 2 ::bglMЈ cassette was excised as an EcoRI-PstI fragment (1.4 kb), end filled, and cloned into pNCKH104. The resulting plasmid, pNCKH113 (Fig. 3) , did not confer ␤-glucanase activity when it was used to transform lactobacilli. Seven unique restriction endonuclease sites (ApaI, SfiI, EagI, NotI, KpnI, SacII, and SmaI) remained available for cloning and screening DNA sequences for promoter activity (Fig. 3) .
To test the efficacy of pNCKH113 as a promoter probe vector, we cloned a 0.9-kb DraI-BclI fragment from pTRK204 that contained the promoter of the erythromycin resistance gene ermC (7) into pNCKH113. Due to the lack of a unique compatible site for BclI in pNCKH113, the promoter fragment was initially cloned into the SmaI and BamHI sites of p29TbglMЈ. It was then recloned into pNCKH104 as a 2.2-kb end-filled EcoRI-PstI fragment incorporating the rrnBT 1 T 2 ::PermC::bglMЈ cassette. The resulting recombinant plasmid, pNCKH114 (Fig. 3) , was used to electrotransform L. reuteri 100-23C. All 40 Em r transformants that were tested produced ␤-glucanase.
This study has provided three important findings concerning a gastrointestinal species of Lactobacillus. First, expression of a ␤-glucanase gene of heterologous origin was demonstrated for the first time for L. reuteri. Second, ␤-glucanase was secreted by the lactobacilli, showing that the B. macerans secretion signals were recognized by the Lactobacillus cells. There is, therefore, the potential to use the secretion signal of BglM to obtain secretion of heterologous peptides by L. reuteri. Third, the derivation of plasmid pNCKH113 has provided a promoter probe vector for use with L. reuteri. These observations provide a useful basis for continuing studies of the genetic modification of gastrointestinal lactobacilli for biotechnological and microecological purposes.
